No abstract available
Keywords:
Crizotinib; Lung adenocarcinoma; MET; Splice site mutation.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / genetics
-
Adenocarcinoma / pathology
-
Adenocarcinoma of Lung
-
Aged, 80 and over
-
Antineoplastic Agents / therapeutic use
-
Crizotinib
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Mutation
-
Protein Kinase Inhibitors / therapeutic use*
-
Proto-Oncogene Proteins c-met / genetics*
-
Pyrazoles / therapeutic use*
-
Pyridines / therapeutic use*
-
RNA Splice Sites
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
RNA Splice Sites
-
Crizotinib
-
Proto-Oncogene Proteins c-met